Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Similar documents
Clinical & Laboratory Assessment

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

Myelodysplastic Syndromes: Everyday Challenges and Pitfalls

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed

Western Health Specialist Clinics Access & Referral Guidelines

Candidates must answer ALL questions

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

Year 2002 Paper two: Questions supplied by Jo 1

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

Haematology dilemma s to refer or not to refer?

GP refresher course Anaemia. Peter MacCallum Consultant Haematologist Barts Health NHS Trust London January 2018

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

APPROACHING TO PANCYTOPENIA

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

Myelodysplastic Syndrome Case 158

GP CME. James Liang Consultant Haematologist. Created by: Date:

Outline. What is aplastic anemia? 9/19/2012. Aplastic Anemia Current Thinking on the Disease, Diagnosis, and Non-Transplant Treatment Options

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018

FBC interpretation. Dr. Gergely Varga

Leukocytosis - Some Learning Points

Myelodysplastic Syndrome: Let s build a definition

Platelet and WBC disorders

Common Haematological Problems in Primary Care

FBC CASES Vernon Louw Clinical Haematology 2010

Ordering Physician CLIENT,CLIENT. Collected REVISED REPORT

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

2013 AAIM Pathology Workshop

MDS: Who gets it and how is it diagnosed?

Approach to the abnormal CBC

MYELODYSPLASTIC SYNDROMES

Interpreting Blood Tests Part 1. Dr Andrew Smith

Hematologic changes in systemic diseases. Chittima Sirijerachai

Anemia in the elderly. Nattiya Teawtrakul MD., PhD

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Dr Marina Karakantza Consultant Haematologist, NHSBT

Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma

SESSION 1 Reactive cytopenia and dysplasia

There are two main causes of a low platelet count

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Maresce Bizaare AWACC 2013

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital

Diseases Of The Blood

Year 2003 Paper two: Questions supplied by Tricia

Michael Joffe ST6 Haematology SpR

Haemopoiesis. Matthew Hazell Consultant Clinical Scientist Trainee

The importance of thrombocytopenia and its causes

ACCME/Disclosures 4/13/2016. Clinical History

Case Presentation No. 075

PNH Glossary of Terms

Aplastic Anemia Pathophysiology and Approach to Therapy

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital

What is MDS? Epidemiology, Diagnosis, Classification & Risk Stratification

V.N. KARAZIN KHARKOV NATIONAL UNIVERSITY

Aplastic anamia & Sideroblastic anemia

ASPEN MOUNTAIN MEDICAL CENTER. Lab Health Fair

Guidelines for diagnosis and management of Adult Myelodysplastic Syndromes (MDS)

Table 1: biological tests in SMD

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

HAEMATOLOGICAL MALIGNANCY

Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS

namib la UnIVERSITY OF SCIEnCE AnD TECHnOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES

National Comparative Audit of red cell transfusion in Medical Patients Part Two

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014

Let s Look at Our Blood

Anaemias and other Pesky Haematology Questions

Adult Acute leukemia. Matthew Seftel. August

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

PATHOLOGY & PATHOPHYSIOLOGY

UNUSUAL PRESENTATION OF AN USUAL CAUSE OF THROMBOCYTOPENIA SOUTHERN RAILWAY HQ HOSPITAL, PERAMBUR DR. KUMARAN DNB PG

MYELODYSPLASTIC SYNDROME. Vivienne Fairley Clinical Nurse Specialist Sheffield

Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS

Anaemia / SCD/ Bleeding disorders in Children

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

ACCME/Disclosures. History. Hematopathology Specialty Conference Case #4 4/13/2016

Solving Medical Mysteries Deducing diagnoses from clues in the CBC. Donald S. Houston MD PhD FRCPC

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

Paediatric Morphology

South African HIV Clinicians Society Managing adult treatment through case study discussion

NCCP Chemotherapy Regimen

Haematologist-reviewed peripheral blood smear in paediatric practice

Haematology and Haematological Oncology

Correspondence should be addressed to Anas Khanfar;

BONE MARROW EXAMINATION FINDINGS AT AGA KHAN UNIVERSITY HOSPITAL, NAIROBI

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor

Long-term outcome of isolated thrombocytopenia accompanied by hypocellular marrow

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Bone marrow failure. By Zahraa Nasooh Al_Saaty

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Transcription:

Borderline cytopenias Dr Taku Sugai Consultant Haematologist

Borderline cytopenias Neutropenia Thrombocytopenia Anaemia with normal haematinics Two recent cases of cytopenias

Neutropenia ANC of more than 2SD below a normal mean Hillingdon normal range 1.8 7.7 x 10 9 /l Ethnic variation Caucasian: less than 1.5 x 10 9 /l Afro caribbean: less than 1.2 x 10 9 /l

Neutrophil maturation

Common causes of Neutropenia Decreased neutrophil productions Vitamin B12/Folate deficiency Drugs Antibiotics(Penicillins/Cephalosporins/choloramphenicol) Anti epileptic(carbamazepine/phenytoin) Psychiatric drugs(phenothiazine) Anti inflammatory(gold/phenylbutazone) Anti Thyroid drugs(carbimazole/methylthiouracil) Diuretics(Hydrochlorothiazide/bumetanide) Cytotoxic agents Alcohol Viral infections e.g HIV, CMV, EBV, Parvovirus, Hep B MDS/Aplastic Anaemia/Bone marrow infiltration Increased peripheral destructions Hypersplenism Autoimmune disease(sle/ra)

Neutrophil morphology

Neutropenia Which cases to refer? ANC less than 0.5 x 10 9 /l Any neutropenia with history of infections Any cases with other cytopenias Drug induced neutropenia is the commonest cause of isolated neutropenia.

Thrombocytopenia Platelets Below 100x 10 9 /l No significant bleed until below 20 x 10 9 /l Inverse relationship between platelets count and skin bleeding time

Bleeding associated with significant thrombocytopenia Findings Disorder of coagulation Disorder of platelets/ Thrombocytopenia Onset of bleeding Delayed after trauma Immediate after trauma Mucosal bleeding Rare Common Petechiae Rare Characteristics Deep haematomas Characteristics Rare Haemarthrosis Characteristics Rare Bleeding from superficial cuts and scratches Minimal Persistent, often profuse

Platelets clumping

Megakaryopoiesis

Common causes of Thrombocytopenia Decreased platelets productions Vitamin B12/Folate deficiency Drugs Ranitidine Thiazide diuretics Isotretinoin Quinine Heparin Valproic acid Montelukast Interferon Teicoplanin Abciximab/Oral GpIIb/IIIa inhibitors Alcohol Viral infections e.g HIV, ToRCH(HHV6), EBV, Parvovirus, Hep C, Mycoplasma, Helicobacter Haem neoplasm MDS/Aplastic Anaemia/Bone marrow infiltration Increased peripheral destructions Hypersplenism Autoimmune disease(sle/antiphospholipid syndrome) ITP HUS/TTP

Thrombocytopenia Which cases to refer? Platelets count less than 50 x 10 9 /l Any thrombocytopenia with bleeding history Any cases with other cytopenias Drug history and virology screen would be helpful

Anaemia WHO definition (Blanc et al, 1968) Age or Gender Group Children (0.5 5.0) 11 Children (5 12yr) 11.5 Teens (12 15yr) 12.0 Women, nonpregnant(>15yr) Hb threshold (g/dl) 12.0 Women, pregnant 11.0 Men (>15yr) 13.0

Anaemia with normal haematinics Haematological malignancies* Solid organ malignancies Haemolytic anaemia Anaemia of chronic disease* Anaemia 2ndary to renal disease Anaemia 2ndary to liver disease

Anaemia of chronic disease Hb is not less than 9g/dl MCV is normal or mildly reduced(77 82fl) MCH is usually normal Serum iron is reduced Total iron binding capacity(transferrin) reduced Transferrin Saturation mildly reduced Serum Ferritin normal or increased CRP and ESR usually raised(hepcidin increased)

Anaemia of chronic disease Iron metabolism

Anaemia of chronic disease Pathogenesis Reduction in iron granules in bone marrow RBC precursors Direct inhibition by TNFa/IL 1/IL 6 Relative lack of Erythropoietin for the level of haemoglobin(il 1a inhibits Epo secretion)

Anaemia of chronic disease Treatment Treatment of underlying chronic disease Epo treatment Trial of iron for 3 months in selected cases

Anaemia Which cases to refer Unexplained anaemia with significant weight loss Unexplained anaemia with other cytopenias

Case 1 Investigations Hb 15.9 MCV 86.8 WBC 3.0* (4 11) Neu 1.7* (1.8 7.7) Lym 0.7*(1 4.8) Plt 88* (140 400) Na 134 K4.3 U1.7 Cr57 Bil 17 ALP 74 ALT 21 Alb 37 AST34*(8 20)

Diagnosis?

Case 1 Diagnosis HIV positive Hepatitis B positive

Case 2 Mr KS is 32 year old Caucasian male Routine blood test in 2008 No history of infection/mouth ulcers No history of bruising Drinks 4 units/week

Case 2 Investigations 2008 Hb 14.2 MCV 102.6*(80 100) WBC 3.1* (4 11) Neu 0.9* (1.8 7.7) Lym 1.9*(1 4.8) Plt 72* (140 400) Na 142 K3.8 U5.2 Cr90

Case 2 Feb2012 4 weeks history of SOB on exertion 12 months history of lethargy Recent history of easy bruising No history of infections Evidence of clinical anaemia No organomegaly

Case 2 Investigations Feb 2012 Hb 7.6* WBC 1.6* Neu 0.2* Lymp 1.2 Plt 24* Normal clotting Normal renal function/lfts Normal Folate/B12

Diagnosis?

Case 2

Case 2 Blood film

Bone marrow aspiration and trephine biopsy

Case 2 Bone marrow aspirate

Case 2 Bone marrow trephine

Cytogenetics

FISH for Chromosome 7

Diagnosis Myelodysplastic syndrome Refractory Anaemia Excess Blasts 2(Almost AML) Monosomy 7 Small PNH clone

Myelodysplastic Syndrome Clonal disorder of haemopoiesis Incidence 3 5 per 100,000/ year Incidence >20 per 100,000/year over the age of 70 years. 60% of patients over the age of 70 More common in male 1.4M to 1.0F 15% of MDS related to previous chemo T R MDS common after 5 7 years

Incidental 20% MDS Clinical features Lethergy due to anaemia 80% Infections or bleed 20%

MDS Laboratory features Pancytopenia 30 50% Hb <10g/dL Neutrophils <1.8 x 10 9 /L Platelets <100 x 10 9 /L Anaemia & thrombocytopenia/neutro 20% Isolated thrombocytopenia/neutropenia5%

Summary Cases to refer Unexplained anaemia with significant weight loss Unexplained anaemia with other cytopenias Neutropenia <0.5 x 10 9 /l Neutropenia with Hx of infections Thrombocytopenia with Hx of bleeding Multiple cytopenias Detailed Drug history is essential prior to referral

Thank you Any Questions?